Skip to main content

QAAGZX

ETF
QAAGZX · UNKNOWN · 136 holdings

Quick Summary

Price History

Concentration Risk

46,63% Top-heavy
Low risk High risk

The top 10 holdings account for 46,63%. The biggest positions move the needle, but there's enough spread to cushion a single-stock blowup.

Top Holdings Today

Weighted by position size
LLY
▼ -0,11%
UNH
▲ 0,75%
ISRG
▼ -2,19%
SYK
▼ -0,84%
TMO
▼ -2,95%
ARGX
▼ -1,49%
VRTX
▼ -1,37%
BSX
▼ -1,84%
DHR
▼ -2,20%
ALNY
▼ -3,98%
Weighted avg. of top holdings ▼ -1,17%

Sector Allocation

Healthcare
79,56%
Manufacturing
0,46%

Top 10 Holdings

46,63% of fund
LLY Eli Lilly & Co
10,70%
UNH UnitedHealth Group Inc
7,09%
ISRG Intuitive Surgical Inc
4,94%
SYK Stryker Corp
4,45%
TMO Thermo Fisher Scientific Inc
3,96%
ARGX Argenx SE
3,54%
VRTX Vertex Pharmaceuticals Inc
3,26%
BSX Boston Scientific Corp
3,12%
DHR Danaher Corp
3,06%
ALNY Alnylam Pharmaceuticals Inc
2,52%
Other positions
9,32%

All Holdings (136)

Top 10: 46,63% of fund
# Ticker Name Weight Shares Market Value
1 LLY Eli Lilly & Co 10,70% 85 488 70,61 M
2 UNH UnitedHealth Group Inc 7,09% 89 328 46,79 M
3 ISRG Intuitive Surgical Inc 4,94% 65 792 32,58 M
4 SYK Stryker Corp 4,45% 78 853 29,35 M
5 TMO Thermo Fisher Scientific Inc 3,96% 52 560 26,15 M
6 ARGX Argenx SE 3,54% 39 472 23,36 M
7 VRTX Vertex Pharmaceuticals Inc 3,26% 44 425 21,54 M
8 BSX Boston Scientific Corp 3,12% 204 239 20,60 M
9 DHR Danaher Corp 3,06% 98 607 20,21 M
10 ALNY Alnylam Pharmaceuticals Inc 2,52% 61 636 16,64 M
Showing top 10 of 136 holdings · Listed: 90,68% · 9,32% in other positions

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) N/A
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: N/A · EV/EBITDA: N/A
P/E Ratio N/A Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap N/A Enterprise Value N/A

Per Share

EPS: N/A · FCF/Share: N/A
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: N/A · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Comparaison Sectorielle

vs médiane du secteur ETF (25157 pairs)
Métrique Action Médiane du Secteur
P/E
P/B
ROE %
Net Margin %
Rev Growth 5Y %
D/E